Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06505, USA; Yale Cancer Biology Institute, Yale West Campus, West Haven, CT 06516, USA.
Trends Biochem Sci. 2022 Oct;47(10):875-891. doi: 10.1016/j.tibs.2022.04.011. Epub 2022 May 16.
Progress towards understanding catalytically 'dead' protein kinases - pseudokinases - in biology and disease has hastened over the past decade. An especially lively area for structural biology, pseudokinases appear to be strikingly similar to their kinase relatives, despite lacking key catalytic residues. Distinct active- and inactive-like conformation states, which are crucial for regulating bona fide protein kinases, are conserved in pseudokinases and appear to be essential for function. We discuss recent structural data on conformational transitions and nucleotide binding by pseudokinases, from which some common principles emerge. In both pseudokinases and bona fide kinases, a conformational toggle appears to control the ability to interact with signaling effectors. We also discuss how biasing this conformational toggle may provide opportunities to target pseudokinases pharmacologically in disease.
在过去的十年中,人们对生物学和疾病中催化“失活”的蛋白激酶 - 拟激酶的理解取得了迅速进展。拟激酶是结构生物学中一个特别活跃的领域,尽管它们缺乏关键的催化残基,但与激酶家族非常相似。对于调节真正的蛋白激酶至关重要的独特的激活和失活样构象状态在拟激酶中得到保守,并似乎对于功能是必需的。我们讨论了最近关于拟激酶构象转变和核苷酸结合的结构数据,从中得出了一些共同的原则。在拟激酶和真正的激酶中,构象转换似乎控制了与信号效应物相互作用的能力。我们还讨论了如何偏向这种构象转换可能为疾病中的拟激酶提供药理学靶向的机会。